{"count":220751,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1996","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=1994","results":[{"created":"2020-01-09T14:46:35.653987+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.81","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: LAMA5 as Amber List (moderate evidence)","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:46:35.646990+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.81","user_name":"Chirag Patel","item_type":"entity","text":"Gene: lama5 has been classified as Amber List (Moderate Evidence).","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:46:05.620913+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.81","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: LAMA5 as Amber List (moderate evidence)","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:46:05.610648+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.81","user_name":"Chirag Patel","item_type":"entity","text":"Gene: lama5 has been classified as Amber List (Moderate Evidence).","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:45:36.186067+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.80","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: LAMA5 as Amber List (moderate evidence)","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:45:36.177330+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.80","user_name":"Chirag Patel","item_type":"entity","text":"Gene: lama5 has been classified as Amber List (Moderate Evidence).","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:45:06.701673+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.80","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: LAMA5 as Amber List (moderate evidence)","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:45:06.693747+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.80","user_name":"Chirag Patel","item_type":"entity","text":"Gene: lama5 has been classified as Amber List (Moderate Evidence).","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:44:27.203255+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.79","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: LAMA5: Rating: AMBER; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"LAMA5","entity_type":"gene"},{"created":"2020-01-09T14:43:42.007318+11:00","panel_name":"Eye Anterior Segment Abnormalities_VCGS","panel_id":43,"panel_version":"0.0","user_name":"Chris Richmond","item_type":"entity","text":"gene: JAG1 was added\ngene: JAG1 was added to Eye Anterior Segment Abnormalities_VCGS. Sources: Literature\nMode of inheritance for gene: JAG1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: JAG1 were set to 21730847; 10051485; 18097983; 9951486\nPhenotypes for gene: JAG1 were set to Alagille syndrome 118450\nPenetrance for gene: JAG1 were set to Complete\nReview for gene: JAG1 was set to GREEN\nAdded comment: From PMID 21730847: \"Ocular anomalies are seen in 78-95% of patients, primarily posterior embryotoxon, although other ASDs such as iris hypoplasia and small corneal diameters are also common and irido-corneal synechiae and corectopia have been occasionally reported (PMIDs 10051485, 18097983, 9951486)\" \nSources: Literature","entity_name":"JAG1","entity_type":"gene"},{"created":"2020-01-09T14:43:21.681062+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.79","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: KANK1 as Red List (low evidence)","entity_name":"KANK1","entity_type":"gene"},{"created":"2020-01-09T14:43:21.673949+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.79","user_name":"Chirag Patel","item_type":"entity","text":"Gene: kank1 has been classified as Red List (Low Evidence).","entity_name":"KANK1","entity_type":"gene"},{"created":"2020-01-09T14:42:55.019267+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.79","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: KANK4 as Red List (low evidence)","entity_name":"KANK4","entity_type":"gene"},{"created":"2020-01-09T14:42:54.995363+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.79","user_name":"Chirag Patel","item_type":"entity","text":"Gene: kank4 has been classified as Red List (Low Evidence).","entity_name":"KANK4","entity_type":"gene"},{"created":"2020-01-09T14:42:42.709216+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: KANK1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"KANK1","entity_type":"gene"},{"created":"2020-01-09T14:42:14.923250+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: KANK4: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"KANK4","entity_type":"gene"},{"created":"2020-01-09T14:42:14.038610+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ITSN1 as Green List (high evidence)","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:42:14.029845+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Gene: itsn1 has been classified as Green List (High Evidence).","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:41:44.150969+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ITSN1 as Green List (high evidence)","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:41:44.144505+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Gene: itsn1 has been classified as Green List (High Evidence).","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:41:14.787188+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ITSN1 as Green List (high evidence)","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:41:14.778944+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.78","user_name":"Chirag Patel","item_type":"entity","text":"Gene: itsn1 has been classified as Green List (High Evidence).","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:40:57.845391+11:00","panel_name":"Eye Anterior Segment Abnormalities_VCGS","panel_id":43,"panel_version":"0.0","user_name":"Chris Richmond","item_type":"entity","text":"gene: LAMB2 was added\ngene: LAMB2 was added to Eye Anterior Segment Abnormalities_VCGS. Sources: Literature\nMode of inheritance for gene: LAMB2 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: LAMB2 were set to 21730847; 18672223; 15367484; 20556798\nPhenotypes for gene: LAMB2 were set to Pierson syndrome 609049\nPenetrance for gene: LAMB2 were set to Complete\nReview for gene: LAMB2 was set to GREEN\nAdded comment: From PMID 21730847 review: \"The primary ocular feature is miosis. Other eye defects that are occasionally observed include iris hypoplasia, ectropion uveae, microcornea, glaucoma, cataract, posterior embryotoxon, microphthalmia, posterior lenticonus, microspherophakia, cloudy or enlarged corneas, and generalized anterior segment dysgenesis (PMID 18672223). The full spectrum of mutations and associated phenotypes was recently reviewed (PMID  20556798). The majority of mutations are truncating; while missense mutations are typically associated with later onset of renal disease and lack of neurologic abnormalities, phenotypic variability is not perfectly correlated to LAMB2 genotype\" \nSources: Literature","entity_name":"LAMB2","entity_type":"gene"},{"created":"2020-01-09T14:40:47.031593+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.77","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ITSN1 as Green List (high evidence)","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:40:47.020265+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.77","user_name":"Chirag Patel","item_type":"entity","text":"Gene: itsn1 has been classified as Green List (High Evidence).","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:40:17.116757+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.77","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ITSN1 as Green List (high evidence)","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:40:17.109342+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.77","user_name":"Chirag Patel","item_type":"entity","text":"Gene: itsn1 has been classified as Green List (High Evidence).","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:39:02.619263+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.76","user_name":"Chirag Patel","item_type":"entity","text":"gene: ITSN1 was added\ngene: ITSN1 was added to Proteinuria_VCGS_KidGen. Sources: Literature\nMode of inheritance for gene: ITSN1 was set to BIALLELIC, autosomal or pseudoautosomal\nPublications for gene: ITSN1 were set to PMID: 29773874\nPhenotypes for gene: ITSN1 were set to Early childhood SSNS\nAdded comment: 3 unrelated families with rare ITSN1 variants and SRNS/CNS or SSNS. \nSources: Literature","entity_name":"ITSN1","entity_type":"gene"},{"created":"2020-01-09T14:36:21.492260+11:00","panel_name":"Eye Anterior Segment Abnormalities_VCGS","panel_id":43,"panel_version":"0.0","user_name":"Chris Richmond","item_type":"entity","text":"gene: COL4A1 was added\ngene: COL4A1 was added to Eye Anterior Segment Abnormalities_VCGS. Sources: Literature\nMode of inheritance for gene: COL4A1 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: COL4A1 were set to 21730847; 16598045; 16107487; 20385946\nPhenotypes for gene: COL4A1 were set to Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps 611773; Brain small vessel disease with or without ocular anomalies 175780; Microangiopathy and leukoencephalopathy, pontine 618564\nPenetrance for gene: COL4A1 were set to unknown\nReview for gene: COL4A1 was set to GREEN\nAdded comment: PMID 21730847: \"Anterior segment ocular anomalies (Table 2) including early-onset cataract, ARA, corneal opacities, congenital cataract, microcornea, elevated intraocular pressure, and/or\r\nglaucoma\" \nSources: Literature","entity_name":"COL4A1","entity_type":"gene"},{"created":"2020-01-09T14:33:38.355188+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.75","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: CD2AP as Amber List (moderate evidence)","entity_name":"CD2AP","entity_type":"gene"},{"created":"2020-01-09T14:33:38.348515+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.75","user_name":"Chirag Patel","item_type":"entity","text":"Gene: cd2ap has been classified as Amber List (Moderate Evidence).","entity_name":"CD2AP","entity_type":"gene"},{"created":"2020-01-09T14:32:55.800842+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.74","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: CD2AP: Rating: AMBER; Mode of pathogenicity: None; Publications: PMID: 30612599, 17713465; Phenotypes: Glomerulosclerosis, focal segmental, 3, OMIM #607832; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"CD2AP","entity_type":"gene"},{"created":"2020-01-09T14:31:48.155360+11:00","panel_name":"Eye Anterior Segment Abnormalities_VCGS","panel_id":43,"panel_version":"0.0","user_name":"Chris Richmond","item_type":"entity","text":"gene: FOXC2 was added\ngene: FOXC2 was added to Eye Anterior Segment Abnormalities_VCGS. Sources: Literature\nMode of inheritance for gene: FOXC2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: FOXC2 were set to 12766066; 21730847\nPhenotypes for gene: FOXC2 were set to Lymphedema-distichiasis syndrome 153400\nPenetrance for gene: FOXC2 were set to unknown\nReview for gene: FOXC2 was set to GREEN\nAdded comment: Ocular examination of patients with lymphedema-distichiasis syndrome and mutations in FOXC2, another member of the forkhead family, identified mild ASD, including partial iris hypoplasia, corectopia, reduced corneal diameter, and localized corneal opacification, in those with mutations within the forkhead domain (PMID: 21730847). No subsequent studies have investigated the role of FOXC2 in anterior segment dysgenesis. \nSources: Literature","entity_name":"FOXC2","entity_type":"gene"},{"created":"2020-01-09T14:31:25.663503+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.74","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ARHGAP24 were set to 21911940","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:31:13.226386+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ARHGAP24 as ready","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:31:13.216170+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: arhgap24 has been classified as Red List (Low Evidence).","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:28:52.066389+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.73","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ARHGAP24 were changed from  to FSGS","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:28:05.259449+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.72","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ARHGAP24 were set to ","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:27:21.391003+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.71","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ARHGAP24 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:26:48.147221+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ARHGAP24 as Red List (low evidence)","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:26:48.140366+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.70","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: arhgap24 has been classified as Red List (Low Evidence).","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:26:09.520522+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.69","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ARHGAP24: Rating: RED; Mode of pathogenicity: None; Publications: 21911940; Phenotypes: FSGS; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ARHGAP24","entity_type":"gene"},{"created":"2020-01-09T14:25:39.381494+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.69","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: APOL1 as Red List (low evidence)","entity_name":"APOL1","entity_type":"gene"},{"created":"2020-01-09T14:25:39.374180+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.69","user_name":"Chirag Patel","item_type":"entity","text":"Gene: apol1 has been classified as Red List (Low Evidence).","entity_name":"APOL1","entity_type":"gene"},{"created":"2020-01-09T14:24:59.160878+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: APOL1: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: ; Mode of inheritance: None","entity_name":"APOL1","entity_type":"gene"},{"created":"2020-01-09T14:23:05.876216+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:23:05.867052+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:22:35.081381+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:22:35.071947+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:22:05.795966+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:22:05.788561+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:21:36.614554+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:21:36.607070+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:21:07.824330+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:21:07.816280+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:20:38.085420+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:20:38.078304+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:20:08.279524+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Classified gene: ANLN as Amber List (moderate evidence)","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:20:08.270545+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.68","user_name":"Chirag Patel","item_type":"entity","text":"Gene: anln has been classified as Amber List (Moderate Evidence).","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T14:19:29.214525+11:00","panel_name":"Proteinuria_VCGS_KidGen","panel_id":144,"panel_version":"0.67","user_name":"Chirag Patel","item_type":"entity","text":"reviewed gene: ANLN: Rating: AMBER; Mode of pathogenicity: None; Publications: PMID: 24676636, 30002222; Phenotypes: Focal segmental glomerulosclerosis 8, OMIM #616032; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ANLN","entity_type":"gene"},{"created":"2020-01-09T13:51:08.604364+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: SLC25A13 as ready","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:51:08.597683+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc25a13 has been classified as Red List (Low Evidence).","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:51:06.066696+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.5","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: SLC25A13 were changed from  to Citrullinemia, adult-onset type II, MIM#603471; Citrullinemia, type II, neonatal-onset, MIM#605814","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:50:55.570763+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.4","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: SLC25A13 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:50:48.934933+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: SLC25A13 as Red List (low evidence)","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:50:48.928135+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.3","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: slc25a13 has been classified as Red List (Low Evidence).","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:50:40.407616+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: SLC25A13: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Citrullinemia, adult-onset type II, MIM#603471, Citrullinemia, type II, neonatal-onset, MIM#605814; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:44:17.164700+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LPL as ready","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:44:17.157613+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lpl has been classified as Green List (High Evidence).","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:44:12.801806+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.2","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LPL were changed from  to Combined hyperlipidemia, familial, MIM# 144250","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:44:02.940009+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.1","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LPL was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:43:54.269386+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LPL: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Combined hyperlipidemia, familial, MIM# 144250; Mode of inheritance: MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:39:34.243708+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: SLC25A13 was added\ngene: SLC25A13 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: SLC25A13 was set to Unknown","entity_name":"SLC25A13","entity_type":"gene"},{"created":"2020-01-09T13:39:34.188451+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: PCSK9 was added\ngene: PCSK9 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: PCSK9 was set to Unknown","entity_name":"PCSK9","entity_type":"gene"},{"created":"2020-01-09T13:39:34.132299+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: LPL was added\ngene: LPL was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: LPL was set to Unknown","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:39:34.077625+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: LIPA was added\ngene: LIPA was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: LIPA was set to Unknown","entity_name":"LIPA","entity_type":"gene"},{"created":"2020-01-09T13:39:34.023170+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: LDLRAP1 was added\ngene: LDLRAP1 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: LDLRAP1 was set to Unknown","entity_name":"LDLRAP1","entity_type":"gene"},{"created":"2020-01-09T13:39:33.967858+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: LDLR was added\ngene: LDLR was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: LDLR was set to Unknown","entity_name":"LDLR","entity_type":"gene"},{"created":"2020-01-09T13:39:33.910518+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: CYP27A1 was added\ngene: CYP27A1 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: CYP27A1 was set to Unknown","entity_name":"CYP27A1","entity_type":"gene"},{"created":"2020-01-09T13:39:33.856303+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: APOE was added\ngene: APOE was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: APOE was set to Unknown","entity_name":"APOE","entity_type":"gene"},{"created":"2020-01-09T13:39:33.803937+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: APOB was added\ngene: APOB was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: APOB was set to Unknown","entity_name":"APOB","entity_type":"gene"},{"created":"2020-01-09T13:39:33.751452+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: ABCG8 was added\ngene: ABCG8 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: ABCG8 was set to Unknown","entity_name":"ABCG8","entity_type":"gene"},{"created":"2020-01-09T13:39:33.698528+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"entity","text":"gene: ABCG5 was added\ngene: ABCG5 was added to Familial hypercholesterolaemia_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services\nMode of inheritance for gene: ABCG5 was set to Unknown","entity_name":"ABCG5","entity_type":"gene"},{"created":"2020-01-09T13:39:33.666229+11:00","panel_name":"Familial hypercholesterolaemia_VCGS","panel_id":333,"panel_version":"0.0","user_name":"Zornitza Stark","item_type":"panel","text":"Added panel Familial hypercholesterolaemia_VCGS","entity_name":null,"entity_type":null},{"created":"2020-01-09T13:34:58.600231+11:00","panel_name":"Ciliary dyskinesia_VCGS","panel_id":82,"panel_version":"0.2","user_name":"Chern Lim","item_type":"entity","text":"reviewed gene: ZMYND10: Rating: GREEN; Mode of pathogenicity: None; Publications: 23891471, 23891469; Phenotypes: Ciliary dyskinesia, primary, 22, MIM#615444; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ZMYND10","entity_type":"gene"},{"created":"2020-01-09T13:19:59.016934+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: PCSK9 was added\ngene: PCSK9 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: PCSK9 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown\nPhenotypes for gene: PCSK9 were set to Hypercholesterolemia","entity_name":"PCSK9","entity_type":"gene"},{"created":"2020-01-09T13:19:58.963374+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: LPL was added\ngene: LPL was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: LPL was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: LPL were set to Lipoprotein lipase deficiency, Hyperlipoproteinemia, Combined hyperlipidemia, familial","entity_name":"LPL","entity_type":"gene"},{"created":"2020-01-09T13:19:58.909523+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: LMF1 was added\ngene: LMF1 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: LMF1 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: LMF1 were set to Combined lipase deficiency","entity_name":"LMF1","entity_type":"gene"},{"created":"2020-01-09T13:19:58.856688+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: LIPA was added\ngene: LIPA was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: LIPA was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: LIPA were set to Wolman disease, Cholesterol ester storage disease","entity_name":"LIPA","entity_type":"gene"},{"created":"2020-01-09T13:19:58.797399+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: LDLRAP1 was added\ngene: LDLRAP1 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: LDLRAP1 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: LDLRAP1 were set to Hypercholesterolemia","entity_name":"LDLRAP1","entity_type":"gene"},{"created":"2020-01-09T13:19:58.745255+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: LDLR was added\ngene: LDLR was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: LDLR was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: LDLR were set to Hypercholesterolemia","entity_name":"LDLR","entity_type":"gene"},{"created":"2020-01-09T13:19:58.687128+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: GPIHBP1 was added\ngene: GPIHBP1 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: GPIHBP1 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: GPIHBP1 were set to Hyperlipoproteinemia, type ID","entity_name":"GPIHBP1","entity_type":"gene"},{"created":"2020-01-09T13:19:58.628403+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: CREB3L3 was added\ngene: CREB3L3 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: CREB3L3 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown\nPhenotypes for gene: CREB3L3 were set to Hypertriglyceridaemia","entity_name":"CREB3L3","entity_type":"gene"},{"created":"2020-01-09T13:19:58.570015+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOE was added\ngene: APOE was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOE was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: APOE were set to Sea-blue histiocyte disease, Dysbetalipoproteinemia, familial (Hyperlipoproteinemia), Lipoprotein glomerulopathy","entity_name":"APOE","entity_type":"gene"},{"created":"2020-01-09T13:19:58.508382+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOC3 was added\ngene: APOC3 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOC3 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown\nPhenotypes for gene: APOC3 were set to Apolipoprotein C-III deficiency","entity_name":"APOC3","entity_type":"gene"},{"created":"2020-01-09T13:19:58.452513+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOC2 was added\ngene: APOC2 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOC2 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: APOC2 were set to Hyperlipoproteinemia, type Ib","entity_name":"APOC2","entity_type":"gene"},{"created":"2020-01-09T13:19:58.398694+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOB was added\ngene: APOB was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOB was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: APOB were set to Hypobetalipoproteinemia, Hypercholesterolemia","entity_name":"APOB","entity_type":"gene"},{"created":"2020-01-09T13:19:58.342317+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOA5 was added\ngene: APOA5 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOA5 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: APOA5 were set to Hyperchylomicronemia","entity_name":"APOA5","entity_type":"gene"},{"created":"2020-01-09T13:19:58.284945+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: APOA1 was added\ngene: APOA1 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: APOA1 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: APOA1 were set to Amyloidosis, systemic nonneuronopathic, Hypoalphalipoproteinemia","entity_name":"APOA1","entity_type":"gene"},{"created":"2020-01-09T13:19:58.227499+11:00","panel_name":"Hyperlipidaemia_RMH","panel_id":332,"panel_version":"0.0","user_name":"Bryony Thompson","item_type":"entity","text":"gene: ALMS1 was added\ngene: ALMS1 was added to Hyperlipidaemia_RMH. Sources: Expert Review Green,Royal Melbourne Hospital\nMode of inheritance for gene: ALMS1 was set to BIALLELIC, autosomal or pseudoautosomal\nPhenotypes for gene: ALMS1 were set to Alstrom syndrome","entity_name":"ALMS1","entity_type":"gene"}]}